Wed, 6 February 2019
Why game-changing medicines, a revolutionary new treatment for sleep apnea, and the chance to be the Amazon of genetics make these under-the-radar stocks intriguing up-and-comers. Stocks: NVTA, INSP, ALLO, MYOV |
Categories
PodcastArchives
December
S | M | T | W | T | F | S |
---|---|---|---|---|---|---|
1 | 2 | |||||
3 | 4 | 5 | 6 | 7 | 8 | 9 |
10 | 11 | 12 | 13 | 14 | 15 | 16 |
17 | 18 | 19 | 20 | 21 | 22 | 23 |
24 | 25 | 26 | 27 | 28 |
Syndication
Wed, 6 February 2019
Why game-changing medicines, a revolutionary new treatment for sleep apnea, and the chance to be the Amazon of genetics make these under-the-radar stocks intriguing up-and-comers. Stocks: NVTA, INSP, ALLO, MYOV |